Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential

PPC Ip, ANY Cheung - Best practice & research Clinical obstetrics & …, 2011 - Elsevier
Uterine leiomyosarcomas are the most common uterine sarcomas. For clinicians, they are
difficult tumours to manage. Preoperative detection is difficult because of the similarity in …

[HTML][HTML] The biology of uterine sarcomas: a review and update

H Kobayashi, C Uekuri… - Molecular and …, 2013 - build.spandidos-publications.com
Uterine sarcoma is a rare neoplasm, accounting for only 5% of uterine malignancies. The
pathogenesis of uterine sarcoma remains largely unknown, although recent basic science …

[HTML][HTML] Molecular-based immunohistochemical algorithm for uterine leiomyosarcoma diagnosis

A Momeni-Boroujeni, E Yousefi, R Balakrishnan… - Modern Pathology, 2023 - Elsevier
The morphologic assessment of uterine leiomyosarcoma (LMS) may be challenging, and
diagnostic immunohistochemical (IHC) analysis is currently lacking. We evaluated the …

Atypical leiomyomas of the uterus: a clinicopathologic study of 51 cases

A Ly, AM Mills, JK McKenney, BL Balzer… - The American journal …, 2013 - journals.lww.com
Atypical leiomyoma is a well-described smooth muscle neoplasm of the uterus. Only 1 study
has addressed long-term clinical follow-up in a large series, and little is known about the …

Endocervical adenocarcinoma with morphologic features of both usual and gastric types: clinicopathologic and immunohistochemical analyses and high-risk HPV …

T Wada, Y Ohishi, T Kaku, M Aman… - The American Journal …, 2017 - journals.lww.com
The fourth edition of the World Health Organization classification set up new entities of
endocervical adenocarcinoma (ECA), namely the “usual type” and “gastric type.” These 2 …

Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up

AM Mills, A Ly, BL Balzer… - The American journal …, 2013 - journals.lww.com
Cell cycle regulatory protein expression by immunohistochemical assay may have
diagnostic utility in the distinction of uterine leiomyosarcoma from leiomyoma variants. p16 …

[HTML][HTML] Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes

H Şahin, F Karatas, G Coban, Ö Özen… - Journal of …, 2019 - ncbi.nlm.nih.gov
Objective In this study, we aimed to evaluate the clinicopathological features, obstetric, and
oncological outcomes of patients diagnosed with a uterine smooth muscle tumors of …

The clinicopathological study of 21 cases with uterine smooth muscle tumors of uncertain malignant potential: centralized review can purify the diagnosis

D Basaran, A Usubutun, MC Salman… - International Journal of …, 2018 - ijgc.bmj.com
Objective The objective of this study was to investigate the clinicopathological features and
factors associated with recurrence in patients with uterine smooth muscle tumor of uncertain …

Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors

IH Hewedi, NA Radwan, LS Shash - Diagnostic pathology, 2012 - Springer
Background The diagnosis of uterine smooth muscle tumors depends on a combination of
microscopic features. However, a small number of these tumors still pose difficult diagnostic …

Uterine smooth muscle tumors of uncertain malignant potential: a retrospective evaluation of clinical pathology and immunohistochemistry features

M Akbarzadeh-Jahromi, N Todarbary, FS Aslani… - Surgical and …, 2024 - Springer
Background Uterine smooth muscle tumor of uncertain malignant potential (STUMP) is a
group of uterine smooth muscle tumors which cannot be classified as a subtype of …